about
Structure, properties, and engineering of the major zinc binding site on human albuminStructural and immunologic characterization of bovine, horse, and rabbit serum albumins.Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albuminCirculatory zinc transport is controlled by distinct interdomain sites on mammalian albumins.A new gadolinium-based MRI zinc sensorAn outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.Effect of common buffers and heterocyclic ligands on the binding of Cu(II) at the multimetal binding site in human serum albuminLocating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.Evaluation of a potential tigecycline-warfarin drug interaction.Biological inorganic chemistry at the beginning of the 21st century.Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin.Conjugation of a Dipicolyl Chelate to Polypeptide Conjugates Increases Binding Affinities for Human Serum Albumin and Survival Times in Human Serum.Imaging free zinc levels in vivo - what can be learned?Cellular transport and homeostasis of essential and nonessential metals.A second generation MRI contrast agent for imaging zinc ions in vivo.Metal-based anti-diabetic drugs: advances and challenges.Interactive association of drugs binding to human serum albumin.Similarities and differences of copper and zinc cations binding to biologically relevant peptides studied by vibrational spectroscopies.Intrinsically Disordered Regions in Serum Albumin: What Are They For?Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of "N-Terminal Modification" to "Fatty Acid Occupation" of Albumin.Comparison of binding characterization of two antiviral drugs to human serum albumin.X-ray crystallographic and fluorometric analysis of the interactions of rhein to human serum albumin.Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery.Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator.Probing bioinorganic chemistry processes in the bloodstream to gain new insights into the origin of human diseases.A molecular mechanism for modulating plasma Zn speciation by fatty acids.Isolation and characterization of serum albumin from Camelus dromedarius.Redox homeostasis of albumin in relation to alpha-lipoic acid and dihydrolipoic acid.Identification of specific protein carbonylation sites in model oxidations of human serum albumin.Improved selectivity of ZnNa3DTPA vs. Na5DTPA to abstract Cd2+ from plasma proteins in vitro.Superoxide dismutase activity of the naturally occurring human serum albumin-copper complex without hydroxyl radical formation.Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis.Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.Evaluation of the binding of oxovanadium(IV) to human serum albumin.In vitro assessment of chelating agents with regard to their abstraction efficiency of Cd(2+) bound to plasma proteins.Zinc-binding property of the major yolk protein in the sea urchin - implications of its role as a zinc transporter for gametogenesis.Ischemia-modified albumin: Crosstalk between fatty acid and cobalt bindingMetal Species in Biology: Bottom-Up and Top-Down LC Approaches in Applied Toxicological Research
P2860
Q24658366-02F9A0E9-7701-4EA1-BCFA-CD660E190593Q27679534-F89CBDE8-C05D-4C37-A185-FA900CB00E69Q27700781-FC7D1062-AC70-4570-8BE7-DAE75A202433Q30252235-4906BCE9-9711-4FB7-AEA3-00DDAB57044FQ33486687-055C1793-926F-4628-BC0D-EE7159250AACQ33628743-935A56C9-4659-4D7B-A0BF-D6B3A2F99201Q33831050-BE1CD8EE-610B-48BA-BFBD-DC7DCE05DA43Q34212667-01CC7AC4-3863-4517-9DB8-B04B6BF89D49Q34593514-B60C21D5-07C5-4B13-96E1-4911A6B1F96DQ34913839-99DD72B3-1AAE-4D16-B8EE-8416250C156FQ35023180-F3FEE9AB-159E-4D47-AA01-837E09AA435FQ36310984-5608D6C9-7656-4D0E-8461-DEDBC048FEE4Q36410013-84337D3B-1873-4CF2-B6AD-587F259A46FBQ37073603-FAE6CA71-CB3B-4B44-9276-4E33BA332AC0Q37149308-292B0F4F-83A4-4E94-900A-1BC8417609B5Q37900507-31090BF6-81F5-40FC-955F-7D732145A89AQ38192435-57108625-E588-43B2-8010-9E57F271B677Q38891983-0813FE19-D032-48FA-A0A1-9A3EB959A0FDQ39172489-3975BEFE-30D8-4154-B2BA-FBB1F731D002Q39207507-582088A1-FAA2-4DC8-BD34-C8A89ADB6464Q39297626-BF60735F-CA25-4FD2-88FB-AED0325AB07EQ39350813-A9AC370B-5EF0-4FB2-84CB-1E7A02F46A63Q39389273-B149F691-01DE-46B9-ABD8-517A9DB2352AQ39442251-F616572D-6B5A-4F08-B5EA-A44EF29EC153Q39917508-403ED150-52DA-4880-9921-16AFFD3E0D9BQ41470913-CE05DB9D-3E99-4828-9EBE-B699DA05D266Q42256824-2424F2B8-978F-4BA0-BD7E-AEDDCCDA4F16Q42412100-31412C85-2CDD-4615-95CC-47C30207B7E9Q46009522-478F3696-2D1A-4C9E-8AC3-81484E7C0DACQ46186065-DD5C8546-14F7-4D55-9E80-0F3F1CB14A04Q46279123-8BDABA7A-A296-4025-BA64-1B74C03C69B4Q46682227-0C850AE9-8C8F-4350-B915-51A939053B88Q46795399-A4419AE8-D6B9-4C20-A44E-AC38081FAEACQ47942318-1E496D76-B9CA-46D1-BDA8-9ED784E54203Q48432398-075D7704-5E61-4FAD-BD76-360EF55A657AQ48784523-06B254DD-D28F-427D-94B1-B7E1FF46BC4BQ58805331-A752D417-0A5B-4388-9491-CC19A0554C68Q58999393-540E07E8-BB5D-419B-B02F-91F8BCB7CA9D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interdomain zinc site on human albumin
@ast
Interdomain zinc site on human albumin
@en
Interdomain zinc site on human albumin
@nl
type
label
Interdomain zinc site on human albumin
@ast
Interdomain zinc site on human albumin
@en
Interdomain zinc site on human albumin
@nl
prefLabel
Interdomain zinc site on human albumin
@ast
Interdomain zinc site on human albumin
@en
Interdomain zinc site on human albumin
@nl
P2093
P2860
P356
P1476
Interdomain zinc site on human albumin
@en
P2093
Claudia A Blindauer
Darrell Sleep
Peter J Sadler
Stephen Berezenko
P2860
P304
P356
10.1073/PNAS.0436576100
P407
P577
2003-02-21T00:00:00Z